12 completed, 7 unknown, 4 recruiting, 3 active not recruiting. 9 Not applicable, 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 3, Unknown 3, Withdrawn 2, Active not recruiting 1 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Cancer of Esophagus: new trials by email Literature Review of Cancer of Esophagus trials Research Report on Cancer of Esophagus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wet Heparinized Suction for Abdominal Cancer wet heparinzed suction, Microsieve, No heparin flush - Cancer of Pancreas, Cancer of Stomach | Not applicable | Withdrawn | H. Lee Moffitt Cancer Center and Research Institute | 2025-11-25 | 2026-09-17 | |
| A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors CBP-1019 - Cancer, Breast, Cancer, Lung | Phase 1 / Phase 2 | Unknown | Coherent Biopharma (Hefei) Co., Ltd. | 260 | 2023-03-14 | 2024-08-26 |
| Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month - Adenocarcinoma - GEJ, Cancer of Esophagus | Phase 2 | Completed | University of Southampton | 13 | 2021-09-28 | 2026-05-18 |
| Onco-primary Care Networking to Support TEAM-based Care iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted), Control - Blood Pressure, Hypertension | Not applicable | Active not recruiting | Duke University | 313 | 2021-06-14 | 2026-02-20 |
| Surgery As Needed for Oesophageal Cancer - 2 Active surveillance - Cancer of Esophagus | Recruiting | Bas P. L. Wijnhoven | 360 | 2021-03-09 | 2024-02-20 | |
| CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1 Cancer of Esophagus, Esophagogastric Junction Disorder | Recruiting | Heinrich-Heine University, Duesseldorf | 100 | 2021-02-01 | 2024-03-08 | |
| Tempus Priority Study: A Pan-tumor Observational Study Observation - Breast Cancer, Prostate Cancer | Active not recruiting | Tempus AI | 1000 | 2020-10-19 | 2025-05-06 | |
| Radiogenomics in Aerodigestive Tract Cancers Cancer, Lung, Cancer of Esophagus | Completed | Buddhist Tzu Chi General Hospital | 139 | 2020-08-01 | 2024-03-22 | |
| Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer Pembrolizumab, Tadalafil - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | Completed | University of California, San Diego | 7 | 2020-04-07 | 2026-02-12 |
| Impedance Spectroscopy in Esophageal Cancer impedance - Cancer of Esophagus | Not applicable | Completed | Sana Klinikum Offenbach | 67 | 2019-10-09 | 2023-01-17 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Cancer, All Types, Cancer of Liver | Unknown | SpeciCare | 1000 | 2019-03-21 | 2020-12-04 | |
| Early Support in Primary Care for People Starting Treatment for Cancer Anticipatory care planning letter - Cancer of Pancreas, Cancer of Stomach | Not applicable | Completed | NHS Lothian | 46 | 2019-01-01 | 2021-03-09 |
| Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy Medical Consortium - Capsule Endoscopy, Cancer of Stomach | Not applicable | Unknown | Yanqing Li | 10000 | 2018-12-31 | 2019-07-25 |
| Audit of the Spanish EURECCA Esophagogastric Cancer Registry Cancer of Stomach, Cancer of Esophagus | Completed | Parc de Salut Mar | 1839 | 2018-07-26 | 2021-03-16 | |
| Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus Cancer Cancer of Esophagus | Unknown | Aarhus University Hospital Skejby | 56 | 2018-06-25 | 2021-03-23 | |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Clinical Trial Matching - Cancer, Metastatic, Cancer | Recruiting | Massive Bio, Inc. | 50000 | 2018-01-01 | 2025-10-28 | |
| Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer Cancer, Cancer of Pancreas | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 1000 | 2017-12-01 | 2023-06-22 | |
| Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence Blood and Tissue Collection - Esophageal Neoplasm, Esophageal Neoplasms Malignancy Unspecified | Terminated | Mayo Clinic | 11 | 2017-10-01 | 2024-03-22 | |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) Radiation Therapy, Cancer | Completed | DxTerity Diagnostics | 16 | 2017-04-06 | 2024-08-07 | |
| Genomic Testing and Resulting Medical Decisions Genomic testing - Cancer of Unknown Origin, Cancer Refractory | Completed | Arbeitsgemeinschaft medikamentoese Tumortherapie | 1500 | 2017-03-30 | 2025-04-10 |
Showing 20 of 29. Sign in to see all of them.
Esophageal Neoplasms (29) · Stomach Neoplasms (13) · Neoplasms (12) · Pancreatic Neoplasms (9) · Head and Neck Neoplasms (8) · Lung Neoplasms (8) · Colonic Neoplasms (7) · Liver Neoplasms (7) · Breast Neoplasms (6) · Kidney Neoplasms (5) · Prostatic Neoplasms (5) · Urinary Bladder Neoplasms (5) · Uterine Cervical Neoplasms (5) · Neoplasm Metastasis (4) · Ovarian Neoplasms (4)
Digestive System Diseases (29) · Digestive System Neoplasms (29) · Esophageal Diseases (29) · Gastrointestinal Diseases (29) · Neoplasms by Site (29) · Gastrointestinal Neoplasms (28) · Head and Neck Neoplasms (21) · Neoplasms (17) · Stomach Diseases (13) · Endocrine Gland Neoplasms (9) · Endocrine System Diseases (9) · Lung Diseases (9) · Pancreatic Diseases (9) · Respiratory Tract Diseases (9) · Respiratory Tract Neoplasms (9)
Amyloid (1) · Blood Specimen Collection (1) · Docetaxel (1) · Esophagectomy (1) · Genetic Profile (1) · Injections (1) · Irinotecan (1) · Nivolumab (1) · Observation (1) · Pharmaceutical Preparations (1) · Radiotherapy (1) · Referral and Consultation (1) · Surveys and Questionnaires (1) · Tadalafil (1) · Temozolomide (1)
Mayo Clinic (3) · Aarhus University Hospital Skejby (1) · Arbeitsgemeinschaft medikamentoese Tumortherapie (1) · Bas P. L. Wijnhoven (1) · Buddhist Tzu Chi General Hospital (1) · Coherent Biopharma (Hefei) Co., Ltd. (1) · Copenhagen University Hospital, Rigshospitalet (1) · Duke University (1) · DxTerity Diagnostics (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Heinrich-Heine University, Duesseldorf (1) · Jinling Hospital, China (1) · Massive Bio, Inc. (1) · Montefiore Medical Center (1) · NHS Lothian (1)
United States (13) · Germany (3) · China (2) · Denmark (2) · Taiwan (2) · United Kingdom (2) · Austria (1) · India (1) · Netherlands (1) · Puerto Rico (1) · Spain (1) · Sweden (1)
Bas Wijnhoven, Dr. (1) · C S Pramesh, MS, FRCS (1) · Christiane Bruns, MD (1) · Elizabeth Smyth (1) · James A. Posey, M.D. (1) · Jang-MIng Lee, doctor (1) · Jesper F Christensen, PhD (1) · Joseph Califano (1) · Ken Dixon, MD (1) · Kirsty Boyd, PhD (1) · Kristiyana Kaneva, MD, MS, MBA (1) · Lin Shen, MD (1) · Luis Tapias Vargas, MD (1) · Manuel Pera (1) · Mate Knabe, MD (1)
PMID 34371380, PMID 34559362, PMID 34794388, PMID 34988480, PMID 35289694, PMID 37038138